Systemic lupus erythematosus is frequently accompanied by psychiatric manifestations of unknown origin. Although damage of central neurons had been documented, little is known about neurotransmitter systems affected by the autoimmune/inflammatory process. Recent studies on lupus-prone MRL-lpr mice point to imbalanced dopamine function and neurodegeneration in dopamine-rich brain regions. We follow up on anecdotal observations of singly housed mice developing chest wounds. Compulsive grooming and/or skin biting accounted for open lesions, lending itself to the operational term 'self-injurious behavior' (SIB). Low incidence of spontaneous SIB increased significantly after repeated injections of dopamine-2/ 3 receptor (D2/D3R) agonist quinpirole (QNP). To further probe the dopaminergic circuitry and examine whether SIB is associated with development of lupus-like disease, we compared behavioral responses among cohorts that differed in the immune status. Two-week treatment with QNP (intraperitoneal, 0.5 mg kg À1 body weight per day) induced SIB in 60% of diseased MRL-lpr mice, and exacerbated their splenomegaly. Although increased grooming and stereotypy were observed in less symptomatic MRL þ / þ controls, only one mouse (10%) developed SIB. Similarly, SIB was not seen in young, asymptomatic groups despite dissimilar ambulatory responses to QNP. In situ hybridization revealed treatment-independent upregulation of D2R mRNA in substantia nigra of diseased MRL-lpr mice. The above results suggest that development of systemic autoimmunity alters sensitivity of the dopaminergic system and renders MRL-lpr mice prone to SIB. Although pathogenic factors were not examined, we hypothesize that immune and endocrine mechanisms jointly contribute to early neuronal damage, which underlies behavioral deficiency in the adulthood.
Introduction
Systemic lupus erythematosus (SLE) is a chronic autoimmune/inflammatory condition with broad spectrum of clinical manifestations. In addition to skin lesions, alopecia, joint and kidney inflammation, significant number of SLE patients present with diverse neurologic and psychiatric manifestations. They range from diffuse central nervous system (CNS) disorders (for example, acute confusional states, psychosis, anxiety, depression, cognitive deficits) to focal CNS syndromes, such as seizures, chorea and myelopathy. Brain pathology includes a wide range of abnormalities, including multifocal microinfarcts, cortical atrophy, hemorrhage and patchy demyelination. [1] [2] [3] Functional imaging reveals reduced cerebral blood flow in different brain regions. 4 Biochemical markers in the cerebrospinal fluid suggest a widespread neuronal and astrocytic damage, 5 likely induced by inflammatory processes and intrathecal synthesis of matrix metalloproteinases. 6 However, it remains unclear whether generalized or neurotransmitter system-specific lesions engender psychiatric manifestations.
The MRL/MpJ-Fas lpr /J (MRL-lpr) substrain is a well-established preparation in studying pathogenesis of SLE. 7 In addition, due to its high construct validity and adequate MRL/MpJ controls (MRL þ / þ mice), the MRL-lpr substrain has been also considered a useful preparation in understanding the CNS involvement in SLE-like disease. 8, 9 Compared to congenic MRL þ / þ controls, who differ in genome less than 0.1% and develop lupus-like manifestations later, MRL-lpr mice show accelerated systemic autoimmunity and inflammation, develop florid disease by 3 months of age and few live more than 6 months. 7 Importantly, infiltration of leukocytes into the choroid plexus may occur as early as 8 weeks of age, 10 the time point that coincides with excessive production of autoantibodies. Comparable to brain lesions and loss of brain volume in CNS-SLE, 11 a significant proportion of MRL-lpr mice show ventricular enlargement, 12 reduced brain mass, autoimmunity-associated atrophy of neuronal dendrites 13, 14 and bona fide neuronal degeneration. 15, 16 At the onset of SLE-like disease, MRL-lpr mice show a constellation of deficits in emotional reactivity and motivated behavior, operationally defined as 'autoimmunityassociated behavioral syndrome' or AABS. 9 Based on documented role of central monoamines in control of mood and motivation, 17 our recent studies are aimed at examining neurotransmitter perturbations associated with various aspects of AABS.
In our earlier study, we noted that MRL mice may become sensitized after repeated intraperitoneal (i.p.) injections of dopamine-2/3 (D2/D3) agonist quinpirole (QNP), also known as LY171555. 18 This was evidenced by restlessness, agitation, jumping and vigorous chest grooming/biting that led to open wounds (severe effects of 1 mg kg À1 i.p. QNP injections used in a pilot dose-response study are shown on the first video clip). However, to comply with ethical research guidelines, this study was terminated early and incidence rates were not determined. An interesting observation was that upper chest injury matched 'spontaneous' chest wounds in B2-3% of diseased MRL-lpr males, singly housed in our colony (unreported observation). Gross observation of home-cage behavior revealed that open wounds resulted from sustained grooming, skin picking and self-biting (shown in the second video clip). These self-directed actions fulfilled the criteria for selfinjurious behavior (SIB), as previously defined by others. 19, 20 The SIB is a hallmark of the Lesch-Nyhan syndrome and its neurological basis is still poorly understood. Clinical and experimental data suggest that neonatal loss of central dopaminergic transmission, increased serotonergic activity and deficient neurotrophic factors play important roles. [21] [22] [23] Consistent with this knowledge, post-mortem analysis of MRL-lpr brains revealed accumulation of dopamine in paraventricular nucleus and median eminence, as well as increased levels of serotonin in the hippocampus. 18 Functional damage of the nigrostriatal pathway was inferred from excessive rotational behavior after a single injection of a D1/D2-receptor agonist apomorphine. 24 Similarly, acute amphetamine injection (known to enhance responsiveness to sucrose) was ineffective in diseased MRL-lpr mice and correlated with dying neurons in the nucleus accumbens. 25 The possibility that dopaminergic system is affected was further supported by B35% reduction in tyrosine hydroxylase-positive cells in the substantia nigra (SN), and increased number of degenerating neurons in the SN and ventral tegmentum. 24 In summary, several lines of evidence suggested that deficits in dopaminergic transmission underlie certain aspects of AABS including proclivity to SIB.
The present study further probes the dopamine receptor system in cohorts of mice that differ in immune status. Although specific to D2/D3 receptors, QNP can also affect locomotor behavior via the D1 receptor system. 26 Therefore, in situ hybridization for both D1 and D2 receptors was performed. An overall expectation was that repeated QNP administration will induce SIB mainly in diseased MRL-lpr mice, and that such aberrant response will be associated with altered dopamine receptor activity in regions implicated in etiology of SIB. 27 
Materials and methods
To examine whether development of lupus-like disease is critical in behavioral responsiveness to QNP, two age groups were used. Diseased MRL-lpr and less symptomatic age-matched MRL þ / þ mice were employed in Experiment 1, while young, prediseased mice of both substrains were employed in Experiment 2. All protocols were performed in accordance with the rules and regulations of the Canadian Council of Animal Care and approved by the local Animal Research Ethics Board.
Animals
Mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA) and housed four per cage under standard laboratory conditions (light period from 0700-1900 hours, room temperature B221C, humidity B62%, regular rodent chaw and tap water ad libitum, bedding changed every 3-4 days). Thirteen-week-old MRL-lpr and MRL þ / þ males (n = 20 per substrain) were used in Experiment 1. However, the sample size was not equal across variable sets because three mice died prematurely and brain sections were not mounted well enough to allow a reliable counting of radioactivity in four cases in Experiment 2. Four-week-old MRL-lpr and MRL þ / þ mice (n = 10 per substrain) were subjected to identical drug treatment but saline (SAL)-treated groups were not employed. The selective use of the QNP-treated groups was based on the evidence that SAL injections did not discriminate MRL substrains on the basis of grooming or SIB (as reported in the Results section). Brain sections from one young mouse did not mount properly to allow reliable counting of radioactivity, thus reducing the sample size to N = 19. Body mass (further referred as the 'body weight') was assessed on a digital scale before treatments commenced and before the killing.
Drug treatment
Although we did not presently measure pharmacokinetics of QNP, it was reported that after acute oral administration to mice plasma concentrations peak within 15 min, with the majority excreted during first 24 h. 28 Based on its capacity to reliably induce SIB in MRL mice, 18 the daily dose of 0.5 mg kg À1 (i.p.; SigmaAldrich, Oakville, ON, Canada) was selected. Mice were injected with either QNP or equivalent volumes of SAL (0.15-0.25 ml) in the testing room and during the light period (1400-1600 hours). This schedule was kept consistent throughout the study because diurnal mechanisms appear critical in induction of 'dopaminergic behaviors' in mice. 29 For ethical reasons, the QNP treatment was discontinued in mice that produced a bloody wound 1 day before activity levels were measured. Maximum of 15 QNP injections were given during the study, and first incidence of SIB was noted in an MRL-lpr mouse after the 10th injection.
Behavioral testing
Behavioral observations commenced immediately after the i.p. injection. Equal number of mice from each group was filmed for 30 min during the first 2 days. Another filming session was performed approximately 2 weeks later (that is, when SIB was observed). A custom-made apparatus, consisting of two rectangular Plexiglass cylinders (13.5 Â 10.5 Â 35.5 cm), was used for the assessment of QNPinduced behavior ( Figure 1 ). The cylinder was placed on the top of a glass and mirror angled below, so observations could be made from reflections when mouse was facing away from a camera (Sony CDR-TRV27) connected to a professional video cassette recorder (VCR). Two cameras filmed four cylinders, thus allowing simultaneous assessments of a mouse from each group. Behavioral acts were scored from video records with Observer software package (3.0 Noldus, Netherlands). Grooming behavior was defined as a snout contact with other body parts without apparent tissue damage. This largely comprised of licking/grooming of chest, limbs, back and genitals. SIB was defined a posteriori by documenting an open wound, 30 which resulted from excessive skin nibbling, pulling and biting. Grooming/SIB was defined as self-directed activity (or grooming-like behavior) and latency, duration and frequency of its bouts were measured. In addition, wound location and number of injections required to induce first SIB episode were recorded.
Spontaneous locomotor activity QNP significantly affects ambulation in healthy mice. 29 To examine how single and repeated injections of QNP affect ambulatory activity in MRL substrains, computerized activity monitors (AccuScan Instruments, Columbus, OH, USA) were used. The testing room was equipped with 10 activity chambers (40 Â 40 Â 35 cm) with ventilated lids. The chambers were interfaced with a personal computer running VersaMax software from the same manufacturer. Total distance traveled, moving time, speed and stereotypy counts were assessed in 5-min intervals over the 60-min period. If the animal breaks the same beam (or set of beams) repeatedly then the monitor considers that the animal is exhibiting stereotypy (this typically happens during grooming, head bobbing, and so on). Stereotypy count was the number of beam breaks that occur during this period of stereotypic activity. A break in stereotypy of 1 s or more was required to separate one stereotypic episode from the next. Recordings were made after second and 12-15th injections (that is, a mouse with SIB was tested with mice from three other groups on the subsequent day).
Tissue collection
To acutely challenge dopaminergic system, mice were given last injection (SAL or QNP) B60 min before the killing. Subsequently, they were anesthetized with Somnotol (60 mg kg À1 , i.p.; MTC Pharmaceuticals, Cambridge, ON, Canada) and blood was quickly aspirated with a collecting tube by cutting vena cava. Subsequently, animals were perfused intracardially with 20 ml of phosphate-buffered saline and 20 ml of 4% paraformaldehyde. Brains were extracted within 2 min, weighed on an analytical scale (AB54-S, Mettler Toledo, Columbus, OH, USA), and fresh frozen before cutting.
Indices of autoimmunity
High serum levels of anti-nuclear antibodies (ANA) are a hallmark of human and murine forms of SLE. Blood samples were collected, left to coagulate at 41C and centrifuged for 3 min at 7000 r.p.m. Serum was separated from blood clot and stored at À801C until further analysis. ANA levels were measured with the enzyme-linked immunosorbent assay kit (Alpha Diagnostic International, San Antonio, TX, USA), as described before. 31 The data were corrected for background and expressed as relative optical density. Another hallmark of lupus-like disease in MRL-lpr mice is splenomegaly. 7 To examine effects of sustained QNP treatment, wet spleen weight was measured on the analytical scale upon extraction.
D1 and D2 receptor mRNA expression D1 and D2 cDNA plasmids (generously provided by Dr Hermann, Max Planck Institute, Freiburg, Germany) were transformed, isolated and linearized. Constructed probes were subsequently radiolabeled with alpha 35 S-UTP. We used in situ hybridization procedure to measure mRNA expression for D1 and D2 receptors (D1R, D2R) in core and shell areas of nucleus accumbens (NAc and NAs), striatum (Str) and SN. In particular, 16 mm-thick brain sections were exposed to 0.25% acetic anhydride (in 0.1 M triethanolamine-HCl, pH 8.0), dehydrated and delipidated with chloroform. Antisense D1-receptor probe was transcribed from D1R mRNA (538 bp from 1485 to 2022, accession no.: NM 10076) and antisense D2R probe was transcribed from D2R mRNA (837 bp from 302 to 1139, accession no.: X55674) using the Riboprobe System (Promega Biotech, Madison, WI, USA) with alpha- 35 S-UTP (specific activity > 1000 Ci mmol À1 ; Perkin-Elmer, Boston, MA, USA) and T7 and T3 polymerases, respectively. Subsequently, slides were fixed in 4% formaldehyde/ phosphate-buffered saline for 5 min and rinsed 1 Â in phosphate-buffered saline. They were acetylated by rinsing with triethanol amine (TEA)-DEPC-H 2 O and incubating in TEA-acetic anhydride for 10 min. Rinses with 2 Â sodium chloride/citrate (SSC), dehydration/ delipidation with 70, 80, 95 and 100% alcohol (1 min each), chloroform (5 min) and again 100, and 95% EtOH (1 min each) followed. Slides were air dried for at least 30 min before riboprobe hybridization. Radiolabeled probes were diluted in a hybridization buffer and applied to brain sections (approximately 500 000 c.p.m. per section). Slides were incubated overnight at 551C in a humidified chamber. To reduce nonspecific binding of the probe, slides were washed in 20mg ml À1 RNase solution for 30 min at room temperature, followed by 1 h each in 2 Â SSC at 501C, 0.2 Â SSC at 55 and 601C. Finally, they were dehydrated by rinsing in 50, 70, 80 and 90% EtOH with 0.3 M NH 4 OAc and 100% EtOH (1 min each), and air dried for at least 1 h before autoradiography.
Autoradiography and quantification of D1 and D2 mRNA expression Slides and 14 C plastic standards containing known amounts of radioactivity (American Radiochemicals, St Louis, MO, USA) were placed in X-ray cassettes, apposed to film (BioMax MR; Eastman Kodak, Rochester, NY, USA) for 48 h, and developed in an automatic film developer (X-OMAT; Eastman Kodak). For each level/probe, different standard curves were generated by using 14 C plastic standards. Using NIH imaging software, optical densities were measured and converted to DPM (decay per minute) using a Rodbard equation. Separate counts were made on two serial sections and for each hemisphere.
Statistical analysis
The data were initially analyzed by two-way analysis of variance, with Substrain and Treatment as between-group factors. When measures were taken repeatedly (for example, using a same cohort of mice or brain), the time, hemisphere or section were within-group factors in two-way analysis of variance with repeated measures. If significant second-order interaction (for example, Substrain by Treatment by Time) was detected, one-way analysis of variance followed by Bonferroni test was used in the post hoc analysis. w 2 test examined occurrence (that is, frequency) of SIB, while Pearson's test was used to examine relationships between scale variables. Significance level was set at Pp0.05; all computations were performed using the SPSS 13 statistical package. Graphs show mean values7s.e.m. and significant differences of Pp0.05, P < 0.01 and P < 0.001 are indicated by *, ** and ***, respectively.
Results

Diseased mice
Body weight, organ weight and immune status. While the QNP-treated groups gained weight (from B42 g to B44 g) over 2 weeks, SAL-injected males showed comparable body weight (B40 g) at both time points (treatment by time: F(1,35) = 4.096, P = 0.05). As observed earlier, 13, 32 brain mass was consistently lower in MRL-lpr than in MRL þ / þ mice (456710 vs 50876 mg; substrain: F(1,35) = 10.150, P < 0.01), and this was not significantly altered by the QNP treatment (47472 vs 51474 mg).
Increased spleen mass (splenomegaly) in 15-weekold MRL-lpr mice confirmed a more severe form of lupus-like disease (substrain: F(1,35) = 92.861, P < 0.001, Figure 2a) . Importantly, sustained administration of QNP exacerbated their splenomegaly (substrain by treatment: F(1,35) = 13.799, P < 0.001). Serum anti-nuclear antibody levels were higher in MRL-lpr mice (substrain: F(1,35) = 38.579, P < 0.001; Figure 2b ), but sustained QNP treatment did not result in further increase (substrain by treatment: F(1,35) = 0.396, NS). The above data confirmed more severe autoimmune manifestations in 15-week-old MRL-lpr mice, and pointed to a detrimental effect of sustained dopamine receptor activation on splenomegaly.
Grooming and SIB. Grooming latency was longer in mice acutely injected with QNP than in SAL-treated animals, but markedly declined after repeated injections of QNP (treatment by time: F(1,29) = 12.1445, P = 0.002). This shorter latency was associated with increased duration of grooming-like, self-directed activity (time by treatment: F(1,29) = 13.481, P = 0.001, Figure 3a ) and longer groominglike episodes in the QNP-treated groups (treatment: F(1,35) = 31.24, P < 0.001). Interestingly, while chronic SAL treatment increased total grooming time in MRL þ / þ mice, it did not affect the MRL-lpr substrain (substrain by time: F(1, 14) = 6.741, P = 0.021). However, after 2 weeks of QNP treatment six MRL-lpr mice and only one MRL þ / þ mouse developed SIB (w 2 = 4.865, P < 0.05; Figure 3b ). Four MRL-lpr mice developed chest wounds and two others forepaw wounds. One MRL-lpr mouse had wounds both on its paws and chest, as seen in the MRL þ / þ mouse. QNP-treated MRL-lpr mice with open wounds groomed longer than MRL-lpr mice without signs of SIB (t = 3.963, d.f. = 8, P < 0.01). The above data suggest that MRL-lpr mice increased their grooming activity and became self-injurious after repeated exposures to QNP. Conversely, SIB occurred infrequently in QNP MRL þ / þ mice, despite long bouts of grooming activity.
Spontaneous ambulation and stereotypy. Welldocumented substrain discrepancy in spontaneous ambulation 33, 34 was exacerbated by increased activity in MRL þ / þ mice 15-20 min after the second QNP injection (distance, substrain by treatment by time: F(11,396) = 5.401, P < 0.001, Figure 4a ). Increased activity in MRL þ / þ mice was accounted by longer ambulatory time (substrain by treatment by time: F(11,396) = 3.915, P < 0.001), increased locomotor speed (treatment: F(1,36) = 12.101, P = 0.001) and more frequent sterotypic movements between 20 and 40 min (substrain by treatment by time: F(11,396) = 3.915, P < 0.001). These dissimilar responses were abolished after repeated QNP injections. In general, mice chronically treated with QNP reduced their ambulatory activity (treatment: F(1,36) = 8.922, P < 0.01, Figure 4b ), likely due to increased grooming/SIB. The above data set suggests that acute dopaminergic stimulation fails to increase locomotor response in diseased MRL-lpr mice. Conversely, such stimulation increases their selfdirected behavior, which is largely comprised of SIB.
In situ hybridization. As shown on Figure 5a , sustained treatment with QNP consistently lowered D1R mRNA expression in NAc (treatment: F(1,31) = 11.318, P = 0.02), NAs (treatment: F(1,31) = 8.469, P = 0.007) and Str (treatment: F(1,31) = 10.037, P = 0.003). Consistent with the current knowledge, no detectable D1 mRNA levels were found in SN. 35 Conversely, repeated injections of QNP significantly increased D2R mRNA expression in NAc (treatment: F(1,31) = 4.9, P = 0.034) and Str (treatment: F(1,31) = 21.515, P < 0.001; Figure 5b) . A trend for increased expression was also noted in the NAs (treatment: F(1,31) = 3.93, P = 0.056). More importantly, regardless of treatment modality, the SN in diseased MRL-lpr mice showed higher expression of D2 mRNA than in MRL þ / þ controls (substrain: F(1,29) = 5.104, Figure 2 Immune measures at B15 weeks of age. Significant increase in spleen weight and serum anti-nuclear antibodies titer confirmed autoimmune status in MRL-lpr mice. The QNP-induced exacerbation of splenomegaly revealed a relationship between sustained stimulation of dopamine receptors and peripheral immunopathology.
Systemic autoimmunity and central dopamine system S Chun et al P = 0.032). Putative relationship between increased receptor synthesis and aberrant behavior was further supported by significant correlation between D2R mRNA levels in the SN and duration of SIB in QNPtreated mice (r 17 = 0.599, P < 0.009).
Young mice
Body weight and organ weight. The body weight of young MRL-lpr and MRL þ / þ mice did not differ before QNP treatment commenced (20.770.8 vs 22.072.1 g, respectively). Both groups gained weight (6-7 g on average), thus showing no signs of malnutrition or retarded growth. Although less profound than in older animals, spleens in 6-weekold MRL-lpr mice were heavier (8977 mg vs 6574 mg; t 18 = 2.852, P = 0.011) and their brains were lighter (43176 vs 48173 mg; t 18 = 7.36, P < 0.01).
Grooming and SIB. First QNP injection almost abolished grooming in both groups of young mice. Although frequency of episodes increased after 2 weeks of treatment (time: F(1,18) = 6.322, P = 0.022), total duration of grooming was comparable to the earlier time point. Interestingly, comparable to QNPinduced response in adult animals (Figure 3) , two out of 10 young MRL þ / þ males showed excessive grooming (that is, 1444 s and 934 s per 30 min). None of young mice showed signs of SIB.
Spontaneous ambulation and stereotypy. Similar to older groups, young MRL þ / þ controls were more active than MRL-lpr mice after second QNP injection. This difference was abolished by 15th injection (distance, substrain by time: F(1,18) = 8.213, P = 0.01; Figure 6 ). This shift was largely accounted by alterations in moving time (data not shown). Contrary to older mice, which showed comparable ambulatory speeds, young MRL-lpr mice were moving slower than MRL þ / þ controls throughout the study (substrain: F(1,18) = 14.894, P = 0.001), but did not differ in QNP-induced stereotypy (substrain: F(1,18) = 1.063, NS).
In situ hybridization. Consistent with the lack of SIB, D2 mRNA expression in the SN was comparable between young groups (335.9730.1 in MRL-lpr vs 421.7756.1 in MRL þ / þ ; t 17 = 1.304, NS). Representative images from all QNP-treated groups are shown in Figure 7 .
Discussion
The present study reveals that acute injection of QNP failed to increase ambulatory activity and stereotypy in diseased MRL-lpr mice. As expected, repeated administration of QNP induced SIB in diseased, but not in young MRL-lpr mice. Inconsistent with our original hypothesis is the observation that the SALtreated MRL-lpr group showed increased expression of D2R mRNA in SN, thus pointing to a diseaserelated phenomenon, rather than pharmacologically induced response. However, significant correlation within the subgroup that developed SIB suggests that mice with highest levels of D2R mRNA signal are most sensitive to repeated challenge with QNP. The constellation of age-and disease-related CNS dysfunctions was also reported by Petitto et al., 36 who observed increased pre-pulse inhibition in autoimmune (7-and 12-week-old) MRL-lpr mice, and an increased, disease-independent startle response at all ages. Given that pre-pulse inhibition can be blocked with acute injection of QNP at the dose presently used, 37 their observation is consistent with our hypothesis that autoimmunity-induced alterations in the dopamine network underlie certain behavioral deficits in MRL-lpr mice. 25 Present discrepancies in behavioral responses after acute and chronic administration of QNP suggest important role of the D2/D3 receptor system. In addition, exacerbated splenomegaly in MRL-lpr mice is consistent with QNP-induced in vivo enhancement in proliferation of activated splenocytes. 38 As such, observed effects of QNP corroborate the hypothesis on bi-directional communication between central/peripheral dopamine systems and immunity. 39 To our knowledge, QNP-induced SIB was not yet reported in healthy experimental animals, even when QNP was administered directly into the brain. 40 The SIB is most profound feature of Lesch-Nyhan syndrome and common complication in autism, mental retardation and other neuropsychiatric disorders. 19 Considerable amount of evidence points to dysfunction in central dopaminergic neurons and permissive role of serotonergic system. 21 In addition, experimental studies show that an early depletion of dopamine is a necessary condition for SIB induced by dopamine receptor agonists in the adulthood. 41 Accordingly, dopamine neuron denervation and subsequent D2 receptor supersensitivity 42 were proposed to underlie pathogenesis of SIB in humans. 21 We observed earlier that tyrosine-hydroxylase (TH, a critical enzyme in dopamine synthesis) is less abundant in SN and ventral tegmentum of many diseased, pharmacologically unchallenged MRL-lpr mice. 24 Increased staining with Fluoro Jade B suggested a neurodegenerative process in these dopamine-rich regions. If the damage occurs at an early stage of brain development indeed (either in utero or after birth), one may expect major perturbations in behavioral profile when lupus-prone mice reach adulthood. Since onset of serological and peripheral manifestations differs among littermates, dissimilar timing in loss of central dopaminergic neurons may contribute to behavioral heterogeneity and proclivity to SIB in the inbred MRL-lpr substrain. 43 In summary, one may hypothesize that diverse behavioral deficits in MRL-lpr mice are result of complex genetic and perinatal autoimmune mechanisms.
It is known that plasma levels of corticosterone are chronically elevated in diseased MRL-lpr mice. 44 Therefore, the observation that they do not increase locomotor activity after acute QNP injection seems consistent with the evidence that synthetic corticosteroid dexamethasone reduces QNP-induced hyperactivity. 45 On the other hand, dissimilar locomotor responses to QNP in young, asymptomatic MRL-lpr mice raise the possibility that an inherited trait, such as deficiency in FasR-mediated apoptosis 46 and/or an early upregulation in pro-inflammatory cytokines, 47 alters activity of endocrine axes 34, 44 and subsequently impairs responsiveness to pharmacological stressors. 48 The substrain difference in the expression of D2R mRNA in SN was statistically significant, but not profound. Given that relationship between the mRNA signal and receptor supersensitivity is likely a complex, nonlinear biological phenomenon, it is plausible that molecular discrepancy of relatively small magnitude amplifies exponentially into an excessive pharmacological response. This region-specific change in signal expression is a novel, but not surprising observation. It is reminiscent of increased D1 receptor binding in the SN of neonatally dopamine-depleted rats that later developed SIB. 27 The Figure 6 Ambulatory activity in young mice at 4 and 6 weeks of age. The discrepancy in locomotor activity was significantly attenuated after chronic injections, suggesting dissimilar behavioral responsiveness between MRL substrains before profound changes in the immune status occur. majority of nigostriatal dopaminergic neurons express dopamine D2 autoreceptors, which control neuronal excitability. 49 As shown in a model of reserpineinduced dopamine depletion, 50 increased D2R mRNA expression may therefore reflect compensatory physiological response to reduced dopamine pools. More importantly, upregulation in D2R synthesis may further lead to long-term supersensitization ('receptor priming') after sustained exposure to receptor agonists. 51 Consistent with our neuroinflammatory model of CNS-SLE, acute interacerebral injection of bacterial endotoxin produces neurodegeneration in SN only, and dopaminergic neurons seem to be particularly vulnerable. 52 The SN is one of several regions densely populated with microglial cells, 53 and in mesencephalon of MRL-lpr mice, they become activated with the disease progression. 54 One may speculate that in SLE-like disease, microglial activation and neurotoxic metabolites contribute to neuronal loss, as proposed in other autoimmune condition, multiple sclerosis. 55 Dopaminergic neurons may be sensitive to reactive oxygen species because dopamine metabolism involves production of hydrogen peroxide and superoxide radicals. In addition, autooxidation of dopamine produces DA-quinone, 56 a metabolite that damages proteins by reacting with cysteine residues. Since excessive levels of dopamine can be neurotoxic 57, 58 one may hypothesize that accumulated dopamine metabolites contribute to loss in dopamine-neuron rich SN. Indeed, we detected earlier a significant accumulation of dopamine in the median eminence and the paraventricular nucleus, 18 as well as reduced number of TH þ cells in SN and ventral tegmentum. 24 Other factors, such as metalloproteinases 59 and prostaglandins, 60 have been also considered in neurodegeneration of inflammatory type. Our recent study excluded COX-dependent mechanisms 54 and steered future research towards the role of brain-reactive autoantibodies. [61] [62] [63] Taken together, diseased MRL-lpr mice may develop an neuro-immuno-endocrine mechanism, which leads to impaired catabolism of dopamine, loss of dopaminergic neurons, receptor supersensitivity and constellation of behavioral deficits, including SIB. However, it is possible that other functionally related neurotransmitter systems, such as glutamate, 64 are also affected during systemic lupus-like disease in MRL-lpr mice. 65 As with other animal models in psychiatry, any extrapolation of experimental data to human disease requires extreme care. Therefore, at this point, we can merely speculate that SIB is relevant etiologically to certain psychiatric manifestations of SLE (for example, psychosis, depression, dementia). If so, it would be more than exciting to identify mediators and molecular mechanisms that alter sensitivity of receptor systems and account for abnormal behavior.
